Diadema Partners »

Cue Biopharma shares owned by Diadema Partners

Quarter-by-quarter ownership of Cue Biopharma shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $30k 132k 0.23

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Capital Management
Lion Point Capital
Geode Capital Management
Vanguard Fiduciary Trust
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Angeles Wealth Management
Advisory Research
Stifel Financial
Renaissance Technologies
Bank of America Corporation
State Street Corporation

View all funds holding Cue Biopharma